about
Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical updateAlternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients.Clinical endpoints in trials of drugs for cancer: time for a rethink?Ancestry and pharmacogenetics of antileukemic drug toxicityThe Barretos short instrument for assessment of quality of life (BSIqol): development and preliminary validation in a cohort of cancer patients undergoing antineoplastic treatment.Quick-FLIC: validation of a short questionnaire for assessing quality of life of cancer patients.Issues in online patient self-reporting of health status.Influx transporter variants as predictors of cancer chemotherapy-induced toxicity: systematic review and meta-analysis.Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study.Effectiveness of an Intervention to Promote Self-Efficacy on Quality of Life of Patients with Nasopharyngeal Carcinoma of the Zhuang Tribe Minority in Guangxi, China: A Prospective Study.Effects of caloric intake on intestinal mucosal morphology and immune cells in rats treated with 5-FluorouracilIntegrating cancer patients' perspectives into treatment decisions and treatment evaluation using patient-reported outcomes--a concept paper.Questionnaire-based assessment of owner concerns and doctor responsiveness: 107 canine chemotherapy patients.Early supplementation of parenteral nutrition is capable of improving quality of life, chemotherapy-related toxicity and body composition in patients with advanced colorectal carcinoma undergoing palliative treatment: results from a prospective, ranCancer-related post-treatment pain and its impact on health-related quality of life in breast cancer patients: a cross sectional study in Palestine.Use of accelerometry to investigate physical activity in dogs receiving chemotherapy.QoL evaluation of olanzapine for chemotherapy-induced nausea and vomiting comparing with 5-HT3 receptor antagonist.Comparing two versions of the Schedule for Evaluation of Individual Quality of Life in patients with advanced cancer.Association between operative technique and intrusive thoughts on health-related Quality of Life 3 years after APE/ELAPE for rectal cancer: results from a national Swedish cohort with comparison with normative Swedish data.
P2860
Q26778004-83C6BFBD-E8E9-4C70-B3CB-CAFB976EA8EBQ30665974-C7F67115-7136-47DE-91D9-26E3B7E21981Q34674821-F3B86A69-85BD-43D2-AB6C-2C1C85EF73A0Q35828717-46AE7D00-936D-45B7-94F6-A797B1B4BD09Q36521239-97E54354-BA56-42A6-9C60-18F0C923DDB5Q36695073-EACA53C2-A705-4585-9F65-0218A20EA75BQ38240932-6B20DBE2-EDD1-4DE3-A81C-B7D89784DDD0Q38845004-80768E2C-2D0C-4913-83B8-CCD7033790E8Q41125350-17F4762C-5D15-4633-BE07-ADD7014761F0Q41577883-0F8D72C3-099F-4F84-92BE-4F656D015F0BQ41940852-B96CB2DC-35FC-4BC2-A75D-3EF2BDBF864AQ42610917-45C17621-23EF-4212-B804-10AC7EEBD945Q42666816-D843BCCC-F186-4A1A-A686-CBBF5AE65137Q43246930-7AEFCCB8-D137-4FE0-9D41-765900ABA7E6Q47118598-F7D6F6EC-8AE9-45AF-9C1C-8B4D0BFCB001Q47634488-CCEC57B3-6C39-47CB-A689-D783E96F1E03Q48016196-E8A3A0DE-A84B-4094-9A60-31007A18C479Q53050076-B29F94B6-4B79-4BE6-8612-92FE3F0150F5Q55311898-8CBFD664-8C13-4935-B27C-404873CDE5DF
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Assessment of quality of life during chemotherapy.
@ast
Assessment of quality of life during chemotherapy.
@en
Assessment of quality of life during chemotherapy.
@nl
type
label
Assessment of quality of life during chemotherapy.
@ast
Assessment of quality of life during chemotherapy.
@en
Assessment of quality of life during chemotherapy.
@nl
prefLabel
Assessment of quality of life during chemotherapy.
@ast
Assessment of quality of life during chemotherapy.
@en
Assessment of quality of life during chemotherapy.
@nl
P1433
P1476
Assessment of quality of life during chemotherapy.
@en
P2093
SBU-group. Swedish Council of Technology Assessment in Health Care
P304
P356
10.1080/02841860151116222
P577
2001-01-01T00:00:00Z